000538.SZ
000538.SZ
CNE0000008X7
YUNNAN BAIYAO
Loading chart...

Company Profile

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Related stocks

688506.SS
688506.SS • China
SICHUAN BIOKIN PHARMACEUTICAL C
229.33 CNY
14.17B USD 1Y -37.4%
002001.SZ
002001.SZ • China
NHU
26.58 CNY
12.22B USD 1Y +6.1%
600196.SS
600196.SS • China
SHANGHAI FOSUN PHARMACEUTICAL G
23.89 CNY
9.55B USD 1Y -19.9%
000999.SZ
000999.SZ • China
CR SANJIU
24.82 CNY
6.18B USD 1Y -12.3%
4507.T
4507.T • Japan
SHIONOGI & CO
2,744.5 JPY
14.76B USD 1Y +8%
600085.SS
600085.SS • China
BEIJING TONG REN TANG CO
24.28 CNY
4.98B USD 1Y -29.3%
1276.HK
1276.HK • China
HENGRUI PHARMA
48 HKD
40.6B USD 1Y -45.3%
3692.HK
3692.HK • China
HANSOH PHARMA
31.54 HKD
24.37B USD 1Y -14.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
21.1% p.a.
Max Drawdown (5Y)
-41.0%
Sharpe Ratio (5Y)
-0.39
Beta Factor
0.12
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Historical Stress Test: Maximum peak-to-trough drawdown of -59.8% in the extended horizon.
ende